Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of 11 Phase 2/3 Clinical Studies in Psoriasis and Psoriatic Arthritis

被引：0

作者：

Strober, Bruce ^{[1
,2
]}

Coates, Laura ^{[3
]}

Yu, Jenny ^{[4
]}

Rowland, Katelyn ^{[5
]}

Leibowitz, Evan ^{[5
]}

Miller, Megan ^{[4
]}

Kollmeier, Alexa ^{[6
]}

Li, Shu ^{[4
]}

Wang, Yanli ^{[4
]}

Chan, Daphne ^{[5
]}

Chakravarty, Soumya ^{[7
,8
]}

Yang, Ya-Wen ^{[9
]}

Shawi, May ^{[9
]}

Lebwohl, Mark ^{[10
]}

Rahman, Proton ^{[11
]}

机构：

[1] Yale Univ, New Haven, CT USA

[2] Cent Connecticut Dermatol Res, Cromwell, CT USA

[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[4] Janssen Res & Dev LLC, Spring House, CA USA

[5] Janssen Sci Affairs LLC, Horsham, PA USA

[6] Janssen Cilag Res & Dev LLC, San Diego, CA USA

[7] Drexel Univ, Coll Med, Villanova, PA USA

[8] Janssen Sci Affairs LLC, Villanova, PA USA

[9] Janssen Pharmaceut Companies Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA

[10] Icahn Sch Med Mt Sinai, New York, NY USA

[11] Mem Univ, St John, NF, Canada

来源：

ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2120

引用

页码：4199 / 4202

页数：4

共 50 条

[1] SAFETY OF GUSELKUMAB IN PATIENTS WITH PSORIATIC DISEASE: AN INTEGRATED ANALYSIS OF 11 PHASE 2 AND 3 CLINICAL STUDIES IN PSORIASIS AND PSORIATIC ARTHRITIS
Strober, Bruce
Coates, Laura
Yu, Jenny
Rowland, Katelyn
Leibowitz, Evan
Miller, Megan
Kollmeier, Alexa
Li, Shu
Wang, Yanli
Chan, Daphne
Chakravarty, Soumya
Yang, Ya-Wen
Shawi, May
Lebwohl, Mark
Rahman, Proton
[J]. RHEUMATOLOGY, 2023, 62
[2] SAFETY OF GUSELKUMAB ACROSS DIVERSE PATIENT SUBGROUPS WITH PSORIATIC DISEASE: AN INTEGRATED ANALYSIS OF 11 PHASE 2/3 CLINICAL STUDIES IN PSORIASIS AND PSORIATIC ARTHRITIS
Coates, L.
Strober, B.
Yu, J.
Leibowitz, E.
Rowland, K.
Kollmeier, A.
Miller, M.
Wang, Y.
Li, S.
Chakravarty, S. D.
Chan, D.
Shawi, M.
Yang, Y. W.
Lebwohl, M.
Rahman, P.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1134 - 1135
[3] Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
Bruce Strober
Laura C. Coates
Mark G. Lebwohl
Atul Deodhar
Evan Leibowitz
Katelyn Rowland
Alexa P. Kollmeier
Megan Miller
Yanli Wang
Shu Li
Soumya D. Chakravarty
Daphne Chan
May Shawi
Ya-Wen Yang
Diamant Thaҫi
Proton Rahman
[J]. Drug Safety, 2024, 47 : 39 - 57
[4] Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
Strober, Bruce
Coates, Laura C.
Lebwohl, Mark G.
Deodhar, Atul
Leibowitz, Evan
Rowland, Katelyn
Kollmeier, Alexa P.
Miller, Megan
Wang, Yanli
Li, Shu
Chakravarty, Soumya D.
Chan, Daphne
Shawi, May
Yang, Ya-Wen
Thaci, Diamant
Rahman, Proton
[J]. DRUG SAFETY, 2024, 47 (01) : 39 - 57
[5] Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: Integrated Analysis of Psoriasis and Psoriatic Arthritis Clinical Trial Data
Gordon, Kenneth
Blauvelt, Andrew
Bachelez, Herve
Coates, Laura
Kaplan, Blair
Koetse, Willem
Drogaris, Leonidas
Sinvhal, Ranjeeta
Papp, Kim A.
[J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2791 - 2793
[6] The effect of guselkumab on psoriasis in patients with active psoriatic arthritis: results from a phase 2 study
Gottlieb, A. B.
Wolf-Henning, B.
Helliwell, P.
Deodhar, A.
Ozturk, B.
Xu, X. L.
Xu, S.
Wang, Y.
Zhuang, Y.
Hsia, E.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 36 - 37
[7] The effect of guselkumab on psoriasis in patients with active psoriatic arthritis: Results from a phase 2 study
Gottlieb, A. B.
Boehncke, W-H.
Helliwell, P.
Deodhar, A.
Xu, X. L.
Xu, S.
Wang, Y.
Zhuang, Y.
Hsia, E. C.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB131 - AB131
[8] Risankizumab Long-Term Safety in Patients With Psoriatic Disease: Integrated Interval Analyses From Psoriasis and Psoriatic Arthritis Clinical Trials
Gordon, Kenneth
Blauvelt, Andrew
Coates, Laura C.
Kaplan, Blair
Koetse, Willem
Drogaris, Leonidas
Sinvhal, Ranjeeta
Papp, Kim A.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB219 - AB219
[9] Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Subrata Ghosh
Lianne S. Gensler
Zijiang Yang
Chris Gasink
Soumya D. Chakravarty
Kamyar Farahi
Paraneedharan Ramachandran
Elyssa Ott
Bruce E. Strober
[J]. Drug Safety, 2019, 42 : 751 - 768
[10] AN ANALYSIS OF FATIGUE IN PATIENTS WITH PSORIATIC DISEASE UTILIZING SF-36 VITALITY SCORES: RESULTS THROUGH WEEK 24 IN PHASE 3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS
Merola, J. F.
Liu, Y. H.
Yang, Y. W.
Miller, M.
Shawi, M.
Chan, D.
Khattri, S.
Savage, L.
Boehncke, W. H.
Han, C.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1573 - 1574

← 1 2 3 4 5 →